[{"Assets_0_Q3_USD":154627000.0,"CommonStockSharesOutstanding_0_Q3_shares":27206447.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-27238000.0,"NetIncomeLoss_1_Q3_USD":-16409000.0,"NetIncomeLoss_3_Q3_USD":-59686000.0,"StockholdersEquity_0_Q3_USD":95358000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]